Ankle-brachial index and bone turnover in patients on dialysis

Journal of the American Society of Nephrology

Volumn 26, Issue 2, 2015, Pages 476-483

  London, Gérard M ^a,b   Marchais, Sylvain J ^a   Guérin, Alain P ^b   De Vernejoul, Marie Christine ^c  

^a Nephrology Department GEPIR   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; MINERAL; PARATHYROID HORMONE;

ADULT; ANKLE BRACHIAL INDEX; ARTERY CALCIFICATION; ARTICLE; BONE DISEASE; BONE MASS; BONE TURNOVER; CARDIOVASCULAR RISK; CELL SURFACE; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSLIPIDEMIA; END STAGE RENAL DISEASE; FEMALE; HEMODIALYSIS; HORMONE RESISTANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MINERAL BLOOD LEVEL; OSTEOBLAST; OSTEOCLAST; PARATHYROID HORMONE BLOOD LEVEL; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING; AGE; AGED; BIOPSY; BLOOD; BONE; BONE DENSITY; COMORBIDITY; KIDNEY FAILURE, CHRONIC; METABOLISM; MIDDLE AGED; OSTEOPOROSIS; PATHOLOGY; PATHOPHYSIOLOGY; PERIPHERAL ARTERIAL DISEASE; PHYSIOLOGY; REGRESSION ANALYSIS; RETROSPECTIVE STUDY;

ADULT; AGE FACTORS; AGED; ANKLE BRACHIAL INDEX; BIOPSY; BONE AND BONES; BONE DENSITY; C-REACTIVE PROTEIN; COMORBIDITY; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OSTEOPOROSIS; PARATHYROID HORMONE; PERIPHERAL ARTERIAL DISEASE; REGRESSION ANALYSIS; RENAL DIALYSIS; RETROSPECTIVE STUDIES;

EID: 84923865238     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014020169     Document Type: Article

References (55)

1. Thompson B, Towler DA: Arterial calcification and bone physiology: Role of the bone-vascular axis. Nat Rev Endocrinol 8: 529-543, 2012
2. Schulz E, Arfai K, Liu X, Sayre J, Gilsanz V: Aortic calcification and the risk of osteoporosis and fractures. J Clin Endocrinol Metab 89: 4246-4253, 2004
3. Tankó LB, Christiansen C, Cox DA, Geiger MJ, McNabb MA, Cummings SR: Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J Bone Miner Res 20: 1912-1920, 2005
4. Szulc P, Kiel DP, Delmas PD: Calcifications in the abdominal aorta predict fractures in men: MINOS study. J Bone Miner Res 23: 95-102, 2008
5. Naves M, Rodríguez-García M, Díaz-López JB, Gómez-Alonso C, Cannata-Andía JB: Progression of vascular calcifications is associated with greater bone loss and increased bone fractures. Osteoporos Int 19: 1161-1166, 2008
6. Hyder JA, Allison MA, Wong N, Papa A, Lang TF, Sirlin C, Gapstur SM, Ouyang P, Carr JJ, Criqui MH: Association of coronary artery and aortic calcium with lumbar bone density: The MESA Abdominal Aortic Calcium Study. Am J Epidemiol 169: 186-194, 2009
7. Pennisi P, Russo E, Gaudio A, Veca R, D'Amico F, Mangiafico RA, Laspina M, Tringali G, Signorelli SS, Fiore CE: The association between carotid or femoral atherosclerosis and low bone mass in postmenopausal women referred for osteoporosis screening. Does osteoprotegerin play a role? Maturitas 67: 358-362, 2010
8. London GM, Marty C, Marchais SJ, Guérin AP, Métivier F, de Vernejoul MC: Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol 15: 1943-1951, 2004
9. Parhami F, Garfinkel A, Demer LL: Role of lipids in osteoporosis. Arterioscler Thromb Vasc Biol 20: 2346-2348, 2000
10. Koh JM, Khang YH, Jung CH, Bae S, Kim DJ, Chung YE, Kim GS: Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre- and postmenopausal women: Evidence for a link between systemic inflammation and osteoporosis. Osteoporos Int 16: 1263-1271, 2005
11. Gerdhem P, Obrant KJ: Effects of cigarette-smoking on bone mass as assessed by dual-energy X-ray absorptiometry and ultrasound. Osteoporos Int 13: 932-936, 2002
12. Mody N, Parhami F, Sarafian TA, Demer LL: Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med 31: 509-519, 2001
13. Bridgeman G, Brookes M: Blood supply to the human femoral diaphysis in youth and senescence. J Anat 188: 611-621, 1996
14. Alagiakrishnan K, Juby A, Hanley D, Tymchak W, Sclater A: Role of vascular factors in osteoporosis. J Gerontol A Biol Sci Med Sci 58: 362-366, 2003
15. Griffith JF, Yeung DKW, Tsang PH, Choi KC, Kwok TCY, Ahuja AT, Leung KS, Leung PC: Compromised bone marrow perfusion in osteoporosis. J Bone Miner Res 23: 1068-1075, 2008
16. Laroche M, Pouilles JM, Ribot C, Bendayan P, Bernard J, Boccalon H, Mazieres B: Comparison of the bone mineral content of the lower limbs in men with ischaemic atherosclerotic disease. Clin Rheumatol 13: 611-614, 1994
17. Pennisi P, Signorelli SS, Riccobene S, Celotta G, Di Pino L, La Malfa T, Fiore CE: Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels. Osteoporos Int 15: 389-395, 2004
18. von Mühlen D, Allison M, Jassal SK, Barrett-Connor E: Peripheral arterial disease and osteoporosis in older adults: The Rancho Bernardo Study. Osteoporos Int 20: 2071-2078, 2009
19. Collins TC, Ewing SK, Diem SJ, Taylor BC, Orwoll ES, Cummings SR, Strotmeyer ES, Ensrud KE; Osteoporotic Fractures in Men (MrOS) Study Group: Peripheral artery disease is associated with higher rates of hip bone loss and increased fracture risk in older men. Circulation 119: 2305-2312, 2009
20. Guerrero A, Montes R, Muñoz-Terol J, Gil-Peralta A, Toro J, Naranjo M, González-Pérez P, Martín-Herrera C, Ruiz-Fernández A: Peripheral arterial disease in patients with stages IV and V chronic renal failure. Nephrol Dial Transplant 21: 3525-3531, 2006
21. Liu J-H, Lin H-H, Yang Y-F, Liu Y-L, Kuo H-L, Wang I-K, Chou C-Y, Huang C-C: Subclinical peripheral artery disease in patients undergoing peritoneal dialysis: Risk factors and outcome. Perit Dial Int 29: 64-71, 2009
22. Adragao T, Pires A, Branco P, Castro R, Oliveira A, Nogueira C, Bordalo J, Curto JD, Prata MM: Ankle - brachial index, vascular calcifications and mortality in dialysis patients. Nephrol Dial Transplant 27: 318-325, 2012
23. Wang Y, Guo X, Li J, Hu D, Zhao D, Ma H, Mou Q, Liu J, Xu Y: Predictive value of ankle-brachial index to all-cause mortality and cardiovascular mortality in Chinese patients with chronic kidney disease. Vasa 41: 205-213, 2012
24. Hjortnaes J, Butcher J, Figueiredo JL, Riccio M, Kohler RH, Kozloff KM, Weissleder R, Aikawa E: Arterial and aortic valve calcification inversely correlates with osteoporotic bone remodelling: A role for inflammation. Eur Heart J 31: 1975-1984, 2010
25. Aikawa E, Nahrendorf M, Figueiredo JL, Swirski FK, Shtatland T, Kohler RH, Jaffer FA, Aikawa M, Weissleder R: Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation 116: 2841-2850, 2007
26. -/- mice. Arterioscler Thromb Vasc Biol 27: 2589-2596, 2007
27. Shapiro S, Tatakis DN, Dziak R: Effects of tumor necrosis factor alpha on parathyroid hormone-induced increases in osteoblastic cell cyclic AMP. Calcif Tissue Int 46: 60-62, 1990
28. Massry SG, Coburn JW, Lee DBM, Jowsey J, Kleeman CR: Skeletal resistance to parathyroid hormone in renal failure. Studies in 105 human subjects. Ann Intern Med 78: 357-364, 1973
29. Ureña P, Mannstadt M, Hruby M, Ferreira A, Schmitt F, Silve C, Ardaillou R, Lacour B, Abou-Samra AB, Segre GV, Drüeke T: Parathyroidectomy does not prevent the renal PTH/PTHrP receptor downregulation in uremic rats. Kidney Int 47: 1797-1805, 1995
30. Picton ML, Moore PR, Mawer EB, Houghton D, Freemont AJ, Hutchison AJ, Gokal R, Hoyland JA: Down-regulation of human osteoblast PTH/PTHrP receptor mRNA in end-stage renal failure. Kidney Int 58: 1440-1449, 2000
31. Iwasaki-Ishizuka Y, Yamato H, Nii-Kono T, Kurokawa K, Fukagawa M: Downregulation of parathyroid hormone receptor gene expression and osteoblastic dysfunction associated with skeletal resistance to parathyroid hormone in a rat model of renal failure with low turnover bone. Nephrol Dial Transplant 20: 1904-1911, 2005
32. Slatopolsky E, Finch J, Clay P, Martin D, Sicard G, Singer G, Gao P, Cantor T, Dusso A: A novel mechanism for skeletal resistance in uremia. Kidney Int 58: 753-761, 2000
33. Sage AP, Lu J, Atti E, Tetradis S, Ascenzi M-G, Adams DJ, Demer LL, Tintut Y: Hyperlipidemia induces resistance to PTH bone anabolism in mice via oxidized lipids. J Bone Miner Res 26: 1197-1206, 2011
34. Disthabanchong S, Hassan H, McConkey CL, Martin KJ, Gonzalez EA: Regulation of PTH1 receptor expression by uremic ultrafiltrate in UMR 106-01 osteoblast-like cells. Kidney Int 65: 897-903, 2004
35. Nii-Kono T, Iwasaki Y, Uchida M, Fujieda A, Hosokawa A, Motojima M, Yamato H, Kurokawa K, Fukagawa M: Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells. Kidney Int 71: 738-743, 2007
36. Katz MS, Gutierrez GE, Mundy GR, Hymer TK, Caulfield MP, McKee RL: Tumor necrosis factor and interleukin 1 inhibit parathyroid hormone-responsive adenylate cyclase in clonal osteoblast-like cells by downregulating parathyroid hormone receptors. J Cell Physiol 153: 206-213, 1992
37. Zhou S, Bueno EM, Kim SW, Amato I, Shen L, Hahne J, Bleiberg I, Morley P, Glowacki J: Effects of age on parathyroid hormone signaling in human marrow stromal cells. Aging Cell 10: 780-788, 2011
38. Jono S, Nishizawa Y, Shioi A, Morii H: Parathyroid hormone-related peptide as a local regulator of vascular calcification. Its inhibitory action on in vitro calcification by bovine vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 17: 1135-1142, 1997
39. Jono S, Nishizawa Y, Shioi A, Morii H: 1,25-Dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide. Circulation 98: 1302-1306, 1998
40. Shao J-S, Cheng S-L, Charlton-Kachigian N, Loewy AP, Towler DA: Teriparatide (human parathyroid hormone (1-34)) inhibits osteogenic vascular calcification in diabetic low density lipoprotein receptor-deficient mice. J Biol Chem 278: 50195-50202, 2003
41. Cheng S-L, Shao J-S, Halstead LR, Distelhorst K, Sierra O, Towler DA: Activation of vascular smooth muscle parathyroid hormone receptor inhibits Wnt/beta-catenin signaling and aortic fibrosis in diabetic arteriosclerosis. Circ Res 107: 271-282, 2010
42. Ishikawa M, Akishita M, Kozaki K, Toba K, Namiki A, Yamaguchi T, Orimo H, Ouchi Y: Amino-terminal fragment (1-34) of parathyroid hormone-related protein inhibits migration and proliferation of cultured vascular smooth muscle cells. Atherosclerosis 136: 59-66, 1998
43. Song GJ, Fiaschi-Taesch N, Bisello A: Endogenous parathyroid hormone-related protein regulates the expression of PTH type 1 receptor and proliferation of vascular smooth muscle cells. Mol Endocrinol 23: 1681-1690, 2009
44. Fiaschi-Taesch N, Sicari B, Ubriani K, Cozar-Castellano I, Takane KK, Stewart AF: Mutant parathyroid hormone-related protein, devoid of the nuclear localization signal, markedly inhibits arterial smooth muscle cell cycle and neointima formation by coordinate up-regulation of p15Ink4b and p27kip1. Endocrinology 150: 1429-1439, 2009
45. Saini V, Marengi DA, Barry KJ, Fulzele KS, Heiden E, Liu X, Dedic C, Maeda A, Lotinun S, Baron R, Pajevic PD: Parathyroid hormone (PTH)/PTH-related peptide type 1 receptor (PPR) signaling in osteocytes regulates anabolic and catabolic skeletal responses to PTH. J Biol Chem 288: 20122-20134, 2013
46. Powell WF Jr., Barry KJ, Tulum I, Kobayashi T, Harris SE, Bringhurst FR, Pajevic PD: Targeted ablation of the PTH/PTHrP receptor in osteocytes impairs bone structure and homeostatic calcemic responses. J Endocrinol 209: 21-32, 2011
47. Cejka D, Herberth J, Branscum AJ, Fardo DW, Monier-Faugere M-C, Diarra D, Haas M, Malluche HH: Sclerostin and Dickkopf-1 in renal osteodystrophy. Clin J Am Soc Nephrol 6: 877-882, 2011
48. Pelletier S, Dubourg L, Carlier M-C, Hadj-Aissa A, Fouque D: The relation between renal function and serum sclerostin in adult patients with CKD. Clin J Am Soc Nephrol 8: 819-823, 2013
49. Brandenburg VM, Kramann R, Koos R, Krüger T, Schurgers L, Mühlenbruch G, Hübner S, Gladziwa U, Drechsler C, Ketteler M: Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: A cross-sectional study. BMC Nephrol 14: 219-228, 2013
50. Irie N, Takada Y, Watanabe Y, Matsuzaki Y, Naruse C, Asano M, Iwakura Y, Suda T, Matsuo K: Bidirectional signaling through ephrinA2-EphA2 enhances osteoclastogenesis and suppresses osteoblastogenesis. J Biol Chem 284: 14637-14644, 2009
51. Zerwekh JE, Ruml LA, Gottschalk F, Pak CYC: The effects of twelve weeks of bed rest on bone histology, biochemical markers of bone turnover, and calcium homeostasis in eleven normal subjects. J Bone Miner Res 13: 1594-1601, 1998
52. Faugere MC, Arnala IO, Ritz E, Malluche HH: Loss of bone resulting from accumulation of aluminum in bone of patients undergoing dialysis. J Lab Clin Med 107: 481-487, 1986
53. Wei S, Siegal GP: Mechanisms modulating inflammatory osteolysis: A review with insights into therapeutic targets. Pathol Res Pract 204: 695-706, 2008
54. Schett G: Effects of inflammatory and anti-inflammatory cytokines on the bone. Eur J Clin Invest 41: 1361-1366, 2011
55. London GM, Marchais SJ, Guérin AP, Boutouyrie P, Métivier F, de Vernejoul MC: Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD. J Am Soc Nephrol 19: 1827-1835, 2008